Citation: R. Schirmbeck et J. Reimann, Revealing the potential of DNA-based vaccination: Lessons learned from thehepatitis B virus surface antigen, BIOL CHEM, 382(4), 2001, pp. 543-552
Authors:
Schirmbeck, R
Konig-Merediz, SA
Riedl, P
Kwissa, M
Sack, F
Schroff, M
Junghans, C
Reimann, J
Wittig, B
Citation: R. Schirmbeck et al., Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide, J MOL MED-J, 79(5-6), 2001, pp. 343-350
Authors:
Hennecke, M
Kwissa, M
Metzger, K
Oumard, A
Kroger, A
Schirmbeck, R
Reimann, J
Hauser, H
Citation: M. Hennecke et al., Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs, NUCL ACID R, 29(16), 2001, pp. 3327-3334
Citation: R. Schirmbeck et J. Reimann, Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12, INTERVIROLO, 44(2-3), 2001, pp. 115-123
Authors:
Deml, L
Bojak, A
Steck, S
Graf, M
Wild, J
Schirmbeck, R
Wolf, H
Wagner, R
Citation: L. Deml et al., Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein, J VIROLOGY, 75(22), 2001, pp. 10991-11001
Authors:
Trobonjaca, Z
Leithauser, F
Moller, P
Schirmbeck, R
Reimann, J
Citation: Z. Trobonjaca et al., Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells, J IMMUNOL, 167(3), 2001, pp. 1413-1422
Authors:
Schirmbeck, R
Zheng, X
Roggendorf, M
Geissler, M
Chisari, FV
Reimann, J
Lu, MJ
Citation: R. Schirmbeck et al., Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen, J IMMUNOL, 166(2), 2001, pp. 1405-1413
Authors:
Flesch, IEA
Stober, D
Schirmbeck, R
Reimann, J
Citation: Iea. Flesch et al., Monocyte inflammatory protein-1 alpha facilitates priming of CD8(+) T cellresponses to exogenous viral antigen, INT IMMUNOL, 12(9), 2000, pp. 1365-1370
Authors:
Hornef, MW
Noll, A
Schirmbeck, R
Reimann, J
Autenrieth, IB
Citation: Mw. Hornef et al., DNA vaccination using coexpression of cytokine genes with a bacterial geneencoding a 60-kDa heat shock protein, MED MICROBI, 189(2), 2000, pp. 97-104
Authors:
Kwissa, M
von Kampen, J
Zurbriggen, R
Gluck, R
Reimann, J
Schirmbeck, R
Citation: M. Kwissa et al., Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control, VACCINE, 18(22), 2000, pp. 2337-2344
Authors:
Koletzki, D
Schirmbeck, R
Lundkvist, A
Meisel, H
Kruger, DH
Ulrich, R
Citation: D. Koletzki et al., DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection, J BIOTECH, 84(1), 2000, pp. 73-78
Authors:
Schirmbeck, R
Wild, J
Stober, D
Blum, HE
Chisari, FV
Geissler, M
Reimann, J
Citation: R. Schirmbeck et al., Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen, J IMMUNOL, 164(8), 2000, pp. 4235-4243
Authors:
Deml, L
Schirmbeck, R
Reimann, J
Wolf, H
Wagner, R
Citation: L. Deml et al., Immunostimulatory CpG motifs trigger a T helper-1 immune response to humanimmunodeficiency virus type-1 (HIV-1) gp160 envelope proteins, CLIN CH L M, 37(3), 1999, pp. 199-204
Citation: R. Schirmbeck et J. Reimann, Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells, BIOL CHEM, 380(3), 1999, pp. 285-291
Citation: R. Schirmbeck et al., Adjuvants that enhance priming of cytotoxic T cells to a K-b-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen, INT IMMUNOL, 11(7), 1999, pp. 1093-1102
Authors:
Deml, L
Schirmbeck, R
Reimann, J
Wolf, H
Wagner, R
Citation: L. Deml et al., Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells, J VIROL MET, 79(2), 1999, pp. 205-217
Citation: J. Reimann et R. Schirmbeck, Alternative pathways for processing exogenous and endogenous antigens thatcan generate peptides for MHC class I-restricted presentation, IMMUNOL REV, 172, 1999, pp. 131-152
Authors:
Lu, MJ
Hilken, G
Kruppenbacher, J
Kemper, T
Schirmbeck, R
Reimann, J
Roggendorf, M
Citation: Mj. Lu et al., Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection, J VIROLOGY, 73(1), 1999, pp. 281-289
Authors:
Wild, J
Grusby, MJ
Schirmbeck, R
Reimann, J
Citation: J. Wild et al., Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4(+) T cell dependent, J IMMUNOL, 163(4), 1999, pp. 1880-1887
Citation: R. Schirmbeck et al., Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expression, EUR J IMMUN, 29(5), 1999, pp. 1740-1749